EsoBiotec, which has successfully advanced its ESO-T01 in vivo CAR-T candidate into clinical trials. ESO-T01 is the first in vivo B-cell maturation antigen (BCMA) CAR-T candidate to reach the clinical ...

If the development of blood vessels in the placenta is impaired, fetal growth retardation may result. Scientists from the German Cancer Research Center (DKFZ) and the Mannheim Medical Faculty of ...

An FDA optometry roundup discusses changes in drug approvals and devices used by optometric eye care professionals.

The key processes of skin aging are now being understood in sufficient detail that targeted prescription therapies for ...

The following is a summary of “Identification of a pancreatic stellate cell gene signature and lncRNA interactions associated ...

Leerink Partners analyst Puneet Souda has maintained their bullish stance on TXG stock, giving a Buy rating on January 13.Stay Ahead of the ...

University at Buffalo researchers reveal molecular insights into the neurotoxic effects of PFAS. Per- and polyfluorinated ...

Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus's ...

Bioptimus, a French artificial intelligence model startup, said today it has raised $41 million that will go toward building ...

A new study reveals the potential of two compounds in treating retinitis pigmentosa, a blinding genetic disorder. These compounds, identified through virtual screening, have shown promising results in ...

Certis Oncology Solutions, led by Peter Ellman, President and CEO, is a life science technology company dedicated to realizing the promise of precision oncology. The company’s product is Oncology ...

Juan Celedón and his research team have altered the possibilities of future asthma treatment by uncovering a new way to ...